Join us in Washington, DC
Join us in Washington, DC
June 15-19, 2025
Join us at the DIA 2025 Global Annual Meeting—the ultimate hub for industry visionaries, regulators, government leaders, academics, innovators, and patients. Set in the dynamic city of Washington DC, this premier event invites global stakeholders to unite, collaborate, and ignite transformation in the life sciences.
Just Dropped: The Must-See Agenda!
In a time of rapid change, no one function can move forward alone. DIA 2025 Global Annual Meeting (DIA 2025) brings together regulatory, clinical, safety, and operational leaders to confront shared challenges and design smarter, faster, more connected solutions. From real-time FDA insights to global regulatory and multi-disciplinary collaboration, this is where silos break down and progress accelerates. Join the conversation that’s shaping what’s next.
Announcements and Highlights
-
About
DIA 2025 is more than a meeting: Focus on the future of health.
Learn More -
Agenda
Plan ahead and make the most of every moment!
Discover Today! -
Keynote Speakers
We are thrilled to unveil the DIA2025 esteemed keynote speakers!
Learn More -
Unmissable Short Courses
Short on Time? Get Big Results with Short Courses!
Register Today!
-
Registration is Open!
Register Today!
Learn More -
Welcome Networking Reception
Join us Sunday evening at Planet Word.
Learn More -
Hotels are Open!
Book your stay at an official DIA Hotel!
Book Today! -
Exhibits & Sponsorship!
Secure Your Space Today and Make a Lasting Impression!
Exhibit With Us -
Double the Learning, Double the Value!
Global Annual Meeting + Cell & Gene Co-Located: A Winning Combo!
Learn More
Customer Testimonials
"The DIA meeting is so incredibly valuable from a professional standpoint for the networking, the content…its really super valuable, it's a must-attend meeting."
Program Committee
-
Linda Akunne, MPH • Chief, Project Management Staff, ORO, OND, CDER
FDA, United States -
Venkatraman Balasubramanian, PhD, MBA • Healthcare and Life Sciences Strategic Advisor
VB Insights, LLC, United States -
Greg Ball, PhD • Safety Data Scientist
ASAPprocess, United States -
Amy Bertha • Executive Director, Regulatory Policy and Science
Bayer, United States -
Sanghita Bhattacharya, PhD • Director Data Science Global Function
Johnson & Johnson Innovative Medicine, United States -
Asia Blackwell • Consumer Safety Officer, CBER
FDA, United States -
Claire Blanchette, PMP • Executive Drug Development Program Leader
Daiichi Sankyo, United States -
Tywnia Brewton • Executive Director, Human Resources
Astellas , United States -
James Buchanan, PharmD • President
Covilance LLC, United States -
Mandy Kaur Budwal-Jagait, MSc • Head of GCP
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom -
Meghana Chalasani, MHA • Associate Director for Clinical Trial Innovation, Office of New Drugs, CDER
FDA, United States -
Joan Chambers • Independent Senior Consultant
Tufts Center For the Study of Drug Development, United States -
Rachel Chasse, MS • Associate Director, Digital Science Strategy
AbbVie, United States -
Christine Colvis, PhD • Director, Drug Development Partnership Programs
National Center for Advancing Translational Sciences (NCATS), United States -
Karen Correa, PhD • Vice President, Clinical Development Operations
Boehringer Ingelheim, United States -
Solange Corriol-Rohou, DrMed, MD, PhD •
SCR Consulting, France -
Stephanie Y. Crawford, PhD, MPH, MS • Professor, Pharmacy Systems, Outcomes and Policy
University of Illinois at Chicago, United States -
Alysha Croker, PhD • Director, Strategic and Horizontal Policy
Health Canada, Canada -
Victoria DiBiaso, BSN, MPH, RN • Global Head, Patient Informed Development and Health Value Translation
Sanofi, France -
Megan Doyle, JD, MPH • Associate Vice President, Assistant General Counsel - Diagnostics
Eli Lilly & Company, United States -
Nancy Dreyer, PhD, MPH, FISPE • Founder
Dreyer Strategies LLC, United States -
Joseph Dustin • Founder and Principal
Dauntless Eclinical Strategies, United States -
Jennifer Emerson, PhD, MPH, RN, PMP • Head Quality Analytics & Risk Management
Boehringer Ingelheim, Germany -
Andrew Emmett, MPH • VP, Global Regulatory Policy and Global Intelligence
Pfizer Inc, United States -
Ron Fitzmartin, PhD, MBA • Principal Consultant
Decision Analytics, United States -
Celeste Frankenfeld Lamm • Senior Director, Global Regulatory Affairs – CMC
Merck Sharp & Dohme LLC , United States -
Danielle Friend Economo, PhD • Senior Director, US Head Regulatory Policy and Intelligence
Johnson & Johnson Innovative Medicine, United States -
David Fryrear, MS • Chief Quality Officer
Astellas, United States -
Cheryl Grandinetti, PharmD • Associate Director for Clinical Policy, CDER/OC/OSI/DCCE
FDA, United States -
Courtney Granville, PhD, MPH •
United States -
Lani Hashimoto • Consultant, Patient Experience
Hashimoto Consulting Services, United States -
Sabine Haubenreisser, PhD, MSc • Principal Scientific Administrator, Stakeholders and Communication Division
European Medicines Agency, Netherlands -
Cammilla Horta Gomes, MA, MPharm • Latam Regulatory Policy Lead
Roche, Brazil -
Stacy Hurt, MBA, MHA • Chief Patient Officer
Parexel, United States -
Huong Huynh, PhD • Director of Regulatory Science
Critical Path Institute, United States -
Emily (Xianghong) Jing, PhD • Associate Director for Scientific Coordination, OBP, OPQ, CDER
FDA, United States -
Jeremy Jokinen, PhD, MS • Vice President and Head Global Patient Safety
Argenx, United States -
Dominique Lagrave, PharmD • Chief Regulatory Officer
Accumulus Technologies, United States -
Elizabeth Lange, MPH, MS • Executive Director/ Head of Regulatory Scientific Policy
EMD Serono, United States -
Cathryn C Lee, MSN •
United States -
Jingyu (Julia) Luan, PhD • Executive Regulatory Science Director, BioPharmaceuticals R&D
AstraZeneca, United States -
Demetra Macheras, MBA • Director, Regulatory Policy and Intelligence - Regulatory Affairs
AbbVie, United States -
Nicole Mahoney, PhD • Executive Director US Regulatory Policy & Intelligence
Novartis, United States -
Lindsay McNair, MD, MPH, MS • Principal Consultant
Equipoise Consulting, United States -
Melodi J McNeil, MS, RPh • Director, Regulatory Affairs (Global Regulatory Lead, Oncology Early Development
AbbVie, United States -
David Meats • Director, Regulatory Services & Medical Affairs Management
Certara, United States -
Timothe Menard, PharmD, MSc • Global Head, Quality Excellence Digital | Bioethics Ambassador
F. Hoffmann-La Roche Ltd, Switzerland -
Pallavi Mishra-Kalyani, PhD, MS • Deputy Division Director, DBV, OB, CDER
FDA, United States -
May F Mo, MBA, MS • Executive Director, Biostatistics
Amgen, United States -
Monica Munoz, PharmD, PhD • Division Director, Division of Pharmacovigilance-I, OSE, CDER
FDA, United States -
Lauren Oliva, PharmD, RPh • US Regulatory Policy Lead
Biogen, United States -
Y. Veronica Pei, MD, MEd, MPH • Lead Physician, Associate Director, Biomedical Informatics and Regulatory Review
FDA, United States -
Vada Perkins, DrSc, MSc • Vice President, Global Head of Regulatory Intelligence & Policy
Boehringer Ingelheim, United States -
Ranjini Prithviraj, PhD, PMP • Director, Global Medical Affairs, Publication Management
Regeneron, United States -
Kim Ribeiro, MS • Director Patient Experience & Engagement
Boehringer Ingelheim, United States -
Margaret Richards, PhD, MPH • Open to Work
Pharmacoepidemiology / RWE, United States -
Cynthia Rothblum-Oviatt, PhD • Science Policy Analyst, Rare Disease Team, OND, CDER
FDA, United States -
Leslie Sam • President
Leslie Sam and Associates, LLC, United States -
Earl Seltzer, MBA • Senior Director, Partnerships and Innovation
CTI, United States -
Anjali Shah, PharmD • Executive Director, Business Capabilities and Innovation, WWPS
Bristol-Myers Squibb Company, United States -
Nancy Pire Smerkanich, DrSc, MS • Assistant Professor Regulatory & Quality Sciences
University of Southern California School of Pharmacy, United States -
Elizabeth Somers, MS • Associate Vice President, Global Project and Alliance Management
Merck Sharp & Dohme LLC, United States -
Benjamin Stevens, PhD, MPH • Director CMC Policy and Advocacy
GlaxoSmithKline, United States -
Nancy Linda Styple • Project Management Leader
Bayer AG, United States -
Ling Su, PhD • Research Fellow
Yeehong Business School, China -
Alec Thompson, PharmD, MS • Senior Product Manager, Oncology
Gilead Sciences, United States -
Michael Torok, PhD • Vice President, Global Head of Quality Assurance Programs
Genentech, A Member of the Roche Group, United States -
Phil Tregunno • Deputy Director - Patient Safety Monitoring
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom -
Yoshiaki Uyama, PhD, MS, RPh • Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
James Valentine, JD, MHS • Director
Hyman, Phelps & McNamara, PC, United States -
James Wabby, MHS • Global Head, Regulatory Affairs, Emerging Technologies and Combination Products
AbbVie, United States -
Paula Walker, MA • Global Head of Risk Based Quality Management
Roche Products Ltd., United Kingdom -
Robin Whitsell • President
Whitsell Innovations, Inc., United States -
Amira Deia Younes • Director-Eastern Europe, Middle East & Africa (EEMEA) Global Regulatory Policy
MSD, United Arab Emirates
Stay Connected!
Sign up for our newsletter to get the latest updates, exclusive insights, and special offers delivered straight to your inbox. Be the first to know about upcoming events, new releases, and more. Join our community today!
